News

The acquisition will add manufacturing footprint in the US enabling the company to develop its pipeline of novel cancer product candidates

Samsung to provide end-to-end CDMO services to advance Kineta's novel anti-VISTA antibody for the treatment of solid tumours

Cannabinoids have caught the attention of Pharma and Cosmetic companies alike in recent years, celebrated for their anti-inflammatory, anti-oxidant and anti-bacterial properties in cosmetic products, and neurological and chronic pain benefits on the ph...

Using Veratrak's platform, the CDMO will have full oversight of data, including an audit trail of data and document processes

67,000-square-foot facility at Carlsbad campus is part of CDMO's investment strategy that addresses growing global demand for cell and gene therapies and vaccines

Acquisition will add West Coast coverage to the CDMO's East Coast and European capabilities and enhance its biologics formulation development and fill-finish network

The company will use its orally disintegrating tablet technology Zydis for JOS Pharmaceuticals' licensed CBD product

The emerging biotech company unveils plans for a 1.2 million-sq. ft manufacturing facility in Yangzhou

China-based company could supply up to 380 million doses from July 2021 through to June 2022

The integrated CDMO rolls out services to the broader community of drug manufacturers and developers

Healthcare provision is constantly evolving. Whereas in the past, decision making on treatments for patients was very much the domain of physicians and doctors, patients now feel more empowered to be involved in the decision making process. The healthc...

A new media panel, gene kit and advanced resins help reduce manufacturing costs and increase the viability of gene therapies